Home › Pneumonia › Illinois
Pneumonia clinical trials in Illinois
7 studies for Pneumonia are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Koch Family Medicine, Morton
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
- University of Chicago, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT05848713The APS Phenotyping Study
- Northwestern Memorial Hospital, Chicago
- University of Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT06521502Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Recruiting
12 Months – 71 Months · All sexes · Updated Jan 27, 2026 · NCT06986148Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 7, 2025 · NCT05892614Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Illinois Health, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.